Twist Bioscience (TWST) Change in Receivables (2017 - 2026)

Twist Bioscience (TWST) has reported Change in Receivables for 10 consecutive years, with $14.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Receivables rose 32.79% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $14.5 million (up 2.24% YoY), while the FY2025 annual figure was $22.4 million, up 365.06% from the prior year.
• Change in Receivables rose to $14.2 million in Q1 2026 per TWST's latest filing, from -$6.8 million in the prior quarter.
• Across five years, Change in Receivables topped out at $14.2 million in Q1 2026 and bottomed at -$8.1 million in Q4 2023.
• Historically, Change in Receivables has averaged $2.0 million across 5 years, with a median of $1.8 million in 2022.
• Annual changes were most pronounced in 2022 — Change in Receivables slumped 328.28% — and 2025, when it jumped 1531.96%.
• Twist Bioscience's Change in Receivables stood at $4.1 million in 2022, then plunged by 296.63% to -$8.1 million in 2023, then surged by 156.3% to $4.5 million in 2024, then slumped by 250.45% to -$6.8 million in 2025, then jumped by 308.58% to $14.2 million in 2026.
• Business Quant data shows TWST's Change in Receivables at $14.2 million in Q1 2026, -$6.8 million in Q4 2025, and $7.2 million in Q3 2025.